Celldex Therapeutics Inc (CLDX)

NASDAQ · Biotechnology

41.90
-0.02 (-0.05%)
Updated Aug 18, 6:42 PM ET
AI Rating
Buy
Overall Score
69
Trend
75
Momentum
84
Risk
38

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 20, 2026 120 sessions Aug 14, 2026

AI Analysis

Celldex Therapeutics Inc is trading at $41.90, down 0.05% on the session. The 50 day average sits at $36.05 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 61.9, which reads as strong, and MACD is bullish crossover. Volume is average.

The nearest support is around $33.97 with resistance near $45.14, so that band frames the current range. Average daily movement is roughly $1.68, or about 4.0% of the share price, which is what any stop placement has to allow for. The overall health score of 69 out of 100 combines a trend score of 75, momentum of 84 and a risk score of 38.

Technical indicators

RSI (14)
61.9
strong
MACD
2.025
bullish crossover
SMA 20
38.88
SMA 50
36.05
SMA 200
--
unknown
ATR (14)
1.68
avg daily range
Support
33.97
Resistance
45.14
Volume vs 20d
0.90x
average
Volatility
49.9%
annualised
1 month
+9.90%
3 months
+31.09%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.